CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

EPA:CLA • FR0013426004

1.07 EUR
+0.02 (+1.9%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall CLA gets a fundamental rating of 4 out of 10. We evaluated CLA against 117 industry peers in the Software industry. CLA has an excellent profitability rating, but there are concerns on its financial health. CLA is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • CLA had positive earnings in the past year.
  • CLA had a positive operating cash flow in the past year.
  • In multiple years CLA reported negative net income over the last 5 years.
  • Each year in the past 5 years CLA had a positive operating cash flow.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • CLA's Return On Assets of 54.15% is amongst the best of the industry. CLA outperforms 100.00% of its industry peers.
  • CLA's Return On Equity of 179.32% is amongst the best of the industry. CLA outperforms 99.15% of its industry peers.
  • CLA's Return On Invested Capital of 16.07% is amongst the best of the industry. CLA outperforms 86.32% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLA is above the industry average of 13.32%.
Industry RankSector Rank
ROA 54.15%
ROE 179.32%
ROIC 16.07%
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • With an excellent Profit Margin value of 25.09%, CLA belongs to the best of the industry, outperforming 82.91% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CLA has grown nicely.
  • With a Operating Margin value of 6.64%, CLA perfoms like the industry average, outperforming 56.41% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CLA has grown nicely.
  • CLA has a better Gross Margin (80.16%) than 68.38% of its industry peers.
  • CLA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.64%
PM (TTM) 25.09%
GM 80.16%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • CLA has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CLA has more shares outstanding than it did 1 year ago.
  • CLA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLA has an improved debt to assets ratio.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of 1.15, we must say that CLA is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.15, CLA is doing worse than 67.52% of the companies in the same industry.
  • The Debt to FCF ratio of CLA is 2.40, which is a good value as it means it would take CLA, 2.40 years of fcf income to pay off all of its debts.
  • CLA has a Debt to FCF ratio (2.40) which is comparable to the rest of the industry.
  • CLA has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
  • CLA's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. CLA is outperformed by 82.05% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CLA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 2.4
Altman-Z 1.15
ROIC/WACC2.04
WACC7.88%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that CLA may have some problems paying its short term obligations.
  • With a Current ratio value of 0.83, CLA is not doing good in the industry: 83.76% of the companies in the same industry are doing better.
  • CLA has a Quick Ratio of 0.83. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.80, CLA is doing worse than 86.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.8
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 706.69%, which is quite impressive.
  • Measured over the past years, CLA shows a very strong growth in Earnings Per Share. The EPS has been growing by 152.38% on average per year.
  • The Revenue has decreased by -2.36% in the past year.
  • Measured over the past years, CLA shows a very negative growth in Revenue. The Revenue has been decreasing by -22.02% on average per year.
EPS 1Y (TTM)706.69%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%566.67%
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.92% on average over the next years.
  • Based on estimates for the next years, CLA will show a very negative growth in Revenue. The Revenue will decrease by -37.74% on average per year.
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 0.83, the valuation of CLA can be described as very cheap.
  • Based on the Price/Earnings ratio, CLA is valued cheaper than 100.00% of the companies in the same industry.
  • CLA is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 7.57, which indicates a rather cheap valuation of CLA.
  • Based on the Price/Forward Earnings ratio, CLA is valued cheaply inside the industry as 94.87% of the companies are valued more expensively.
  • CLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 0.83
Fwd PE 7.57
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 98.29% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 99.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 3.21
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • The excellent profitability rating of CLA may justify a higher PE ratio.
  • A cheap valuation may be justified as CLA's earnings are expected to decrease with -3.92% in the coming years.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2Y-3.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CLA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLARANOVA SE

EPA:CLA (2/10/2026, 7:00:00 PM)

1.07

+0.02 (+1.9%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11
Earnings (Next)05-21
Inst Owners5.13%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap61.21M
Revenue(TTM)293.80M
Net Income(TTM)73.70M
Analysts80
Price Target2.45 (128.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-28.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.53%
Valuation
Industry RankSector Rank
PE 0.83
Fwd PE 7.57
P/S 0.21
P/FCF 2.96
P/OCF 2.6
P/B 1.49
P/tB N/A
EV/EBITDA 3.21
EPS(TTM)1.29
EY120.56%
EPS(NY)0.14
Fwd EY13.21%
FCF(TTM)0.36
FCFY33.82%
OCF(TTM)0.41
OCFY38.39%
SpS5.14
BVpS0.72
TBVpS-0.88
PEG (NY)N/A
PEG (5Y)0.01
Graham Number4.57
Profitability
Industry RankSector Rank
ROA 54.15%
ROE 179.32%
ROCE 21.86%
ROIC 16.07%
ROICexc 20.86%
ROICexgc N/A
OM 6.64%
PM (TTM) 25.09%
GM 80.16%
FCFM 7.05%
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
ROICexc(3y)41.64%
ROICexc(5y)35.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.9%
ROCE(5y)19.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-2.71%
ROICexc growth 5Y6.36%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
F-Score8
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 2.4
Debt/EBITDA 1.93
Cap/Depr 70%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 100%
Profit Quality 28.09%
Current Ratio 0.83
Quick Ratio 0.8
Altman-Z 1.15
F-Score8
WACC7.88%
ROIC/WACC2.04
Cap/Depr(3y)69.81%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)706.69%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%566.67%
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.36%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%N/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.72%
EBIT growth 3Y-0.17%
EBIT growth 5Y12.2%
EBIT Next Year-17.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3Y14.47%
FCF growth 5Y-6.06%
OCF growth 1Y-40.81%
OCF growth 3Y13.67%
OCF growth 5Y-4.45%

CLARANOVA SE / CLA.PA FAQ

Can you provide the ChartMill fundamental rating for CLARANOVA SE?

ChartMill assigns a fundamental rating of 4 / 10 to CLA.PA.


Can you provide the valuation status for CLARANOVA SE?

ChartMill assigns a valuation rating of 8 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Undervalued.


How profitable is CLARANOVA SE (CLA.PA) stock?

CLARANOVA SE (CLA.PA) has a profitability rating of 8 / 10.


What is the financial health of CLARANOVA SE (CLA.PA) stock?

The financial health rating of CLARANOVA SE (CLA.PA) is 2 / 10.


Can you provide the expected EPS growth for CLA stock?

The Earnings per Share (EPS) of CLARANOVA SE (CLA.PA) is expected to decline by -46.15% in the next year.